Literature DB >> 20869284

Malignant mixed ovarian germ cell tumor with embryonal component.

Natalie Catharine Moniaga1, Leslie M Randall.   

Abstract

BACKGROUND: Malignant germ cell tumors of the ovary are relatively rare, making up less than 10% of all ovarian cancers. However, although they represent only a small fraction of ovarian cancers overall, they frequently affect adolescent women of reproductive age, making fertility sparing treatment of paramount importance. Malignant germ cell tumors are subdivided into dysgerminoma and nondygerminomatous tumors. The most common types of nondysgerminomatous tumors are yolk sac and immature teratoma. Mixed germ cell tumors with embryonal carcinoma, nongestational choriocarcinoma, and polyembryoma are less common. Embryonal carcinomas, though rare, are one of the most malignant cancers arising in the ovary. CASE: A 19-year-old female with abdominal pain and massive ascites was found to have a malignant mixed ovarian germ cell tumor with a large embryonal component which was treated via surgical resection and chemotherapy.
CONCLUSIONS: Malignant germ cell tumors frequently affect adolescent women of reproductive age. Management of these tumors requires consideration of fertility sparing surgical techniques and chemotherapy management. Using these techniques, the vast majority of patients will maintain their ovarian function and the ability to bear children after their recovery. Copyright Â
© 2011 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20869284      PMCID: PMC5111966          DOI: 10.1016/j.jpag.2010.05.001

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  14 in total

1.  Malignant germ cell tumors of the ovary.

Authors:  K Tewari; F Cappuccini; P J Disaia; M L Berman; A Manetta; M F Kohler
Journal:  Obstet Gynecol       Date:  2000-01       Impact factor: 7.661

2.  Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide.

Authors:  D M Gershenson; L J Copeland; J J Kavanagh; A Cangir; G Del Junco; P B Saul; C A Stringer; R S Freedman; C L Edwards; J T Wharton
Journal:  Cancer       Date:  1985-12-15       Impact factor: 6.860

3.  Incidence and survival rates for female malignant germ cell tumors.

Authors:  Harriet O Smith; Marianne Berwick; Claire F Verschraegen; Charles Wiggins; Letitia Lansing; Carolyn Y Muller; Clifford R Qualls
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

4.  Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary.

Authors:  Shin Nishio; Kimio Ushijima; Akimasa Fukui; Naoki Fujiyoshi; Kouichiro Kawano; Kan Komai; Shunichiro Ota; Keizo Fujiyoshi; Toshiharu Kamura
Journal:  J Obstet Gynaecol Res       Date:  2006-08       Impact factor: 1.730

5.  Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.

Authors:  M Brewer; D M Gershenson; C E Herzog; M F Mitchell; E G Silva; J T Wharton
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

6.  A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites.

Authors:  D M Patterson; N Murugaesu; L Holden; M J Seckl; G J S Rustin
Journal:  Int J Gynecol Cancer       Date:  2007-04-26       Impact factor: 3.437

Review 7.  Management of ovarian germ cell tumors.

Authors:  David M Gershenson
Journal:  J Clin Oncol       Date:  2007-07-10       Impact factor: 44.544

8.  Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.

Authors:  S D Williams; R Birch; L H Einhorn; L Irwin; F A Greco; P J Loehrer
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).

Authors:  R Vriesendorp; J G Aalders; D T Sleijfer; P H Willemse; J Bouma; N H Mulder
Journal:  Cancer Treat Rep       Date:  1984-05

10.  Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study.

Authors:  David M Gershenson; Anna M Miller; Victoria L Champion; Patrick O Monahan; Qianqian Zhao; David Cella; Stephen D Williams
Journal:  J Clin Oncol       Date:  2007-07-01       Impact factor: 44.544

View more
  5 in total

1.  Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.

Authors:  Xiu-Jie Yu; Lin Zhang; Zai-Ping Liu; Yi-Quan Shi; Yi-Xin Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 2.  Laparoscopic treatment of a Yolk Sac Tumor: case report and literature review.

Authors:  Maurizio Guida; Sandro Pignata; Anna Rita Palumbo; Gianmarco Miele; Maria Luisa Marra; Federica Visconti; Fulvio Zullo
Journal:  Transl Med UniSa       Date:  2013-09-02

3.  MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro.

Authors:  Wei-Min Chung; Wei-Chun Chang; Lumin Chen; Ying-Yi Chang; Chih-Rong Shyr; Yao-Ching Hung; Wen-Lung Ma
Journal:  Stem Cell Res Ther       Date:  2013-07-26       Impact factor: 6.832

4.  Malignant Mixed Germ Cell Tumors of the Ovary: A Series of Rare Cases.

Authors:  Lajya Devi Goyal; Balpreet Kaur; Rama Kumari Badyal
Journal:  J Reprod Infertil       Date:  2019 Oct-Dec

5.  [Clinical, therapeutic and prognostic aspects of malignant germ cell tumors of the ovary: experience of 21 years old Tunisian].

Authors:  Imen Ghaddab; Raja Briki; Sassi Bouguizene; Hedi Khairi
Journal:  Pan Afr Med J       Date:  2020-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.